NASDAQ:DNLI | Operating Income | Denali Therapeutics Inc.

Complete source-backed operating income history.

Available history
2016-12-31 to 2026-06-30
Data captured

Historical Operating Income

DateOperating Income
2026-06-30-$130.54M
2026-03-31-$137.36M
2025-12-31-$137.37M
2025-09-30-$137.43M
2025-06-30-$134.96M
2025-03-31-$145.58M
2024-12-31-$129.85M
2024-09-30-$123.19M
2024-06-30-$116.59M
2024-03-31-$117.72M
2023-12-31-$132.57M
2023-09-30-$113.8M
2023-06-30$170.48M
2023-03-31-$120.82M
2022-12-31-$105.34M
2022-09-30-$107.49M
2022-06-30-$61.42M
2022-03-31-$66.5M
2021-12-31-$77.12M
2021-09-30-$85.59M
2021-06-30-$61.82M
2021-03-31-$71.22M
2020-12-31$244.08M
2020-09-30-$60.12M
2020-06-30-$61.28M
2020-03-31-$59.97M
2019-12-31-$57.76M
2019-09-30-$50.16M
2019-06-30-$62.76M
2019-03-31-$42.51M
2018-12-31$74.72M
2018-09-30-$37.96M
2018-06-30-$57.38M
2018-03-31-$25.75M
2017-12-31-$23.54M
2017-09-30-$22.29M
2017-06-30-$22.57M
2017-03-31-$21.74M

Annual Operating Income

DateOperating Income
2025-12-31-$555.34M
2024-12-31-$487.34M
2023-12-31-$196.7M
2022-12-31-$340.74M
2021-12-31-$295.75M
2020-12-31$62.72M
2019-12-31-$213.18M
2018-12-31-$46.37M
2017-12-31-$90.14M
2016-12-31-$87.43M